Visfatin stimulates proliferation of MCF-7 human breast cancer cells. 2010

Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan, 680-749, Korea.

Obesity, a condition characterized by increased fat content and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D016213 Cyclins A large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators. Cyclin

Related Publications

Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
January 2004, International journal of molecular medicine,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
January 2013, Radiology and oncology,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
March 2007, Molecular pharmacology,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
May 1989, Journal of molecular endocrinology,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
May 1998, Cancer letters,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
April 2016, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
January 2015, Cancer cell & microenvironment,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
October 2015, Molecular medicine reports,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
March 2006, Cell biology international,
Jae Geun Kim, and Eun Ok Kim, and Bo Ra Jeong, and Young Joo Min, and Jeong Woo Park, and Eun Sook Kim, and Il Seong Namgoong, and Young Il Kim, and Byung Ju Lee
July 1995, Cancer letters,
Copied contents to your clipboard!